La cadena de opciones muestra datos clave de las opciones de acciones de Alterity Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Alterity Therapeutics..

Alterity Therapeutics (NASDAQ:ATHE) Bolsa, Cadena de Opciones

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.

ALTG

Alterity Therapeutics Limited - American Depositary Shares

ATHE

CARM

CNCK

CRGX

FBNC

MGOL

NAOV

NATR

OFIX

RNGR

SLXN

TSLA

VREX

XFOR

Meta sube en la preapertura tras superar expectativas. Descubre qué otras acciones están registrando fuertes movimientos hoy.

Acciones de Meta Platforms (META) están cotizando al alza; 20 acciones que se mueven en el premercado de EE.UU.

Alterity Therapeutics Ltd

ATHENA BITCOIN GLOBAL by ATHENA BITCOIN GLOBAL

Athena Bitcoin Global

ATHENA GOLD CORP by Athena Gold Corporation

Athena Gold Corp

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 4.875% Fixed-Rate Perpetual Non-Cumulative Preference Share, Series D

Athene Holding Ltd

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 6.35% Fixed-to-Floating Rate Perpetual Non-Cumulative Preference Share, Series A

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 7.750% Fixed-Rate Reset Perpetual Non-Cumulative Preference Share, Series E

Athene Holding Ltd. 7.250% Fixed-Rate Reset Junior Subordinated Debentures due 2064

Athene Holding Ltd. Depositary Shares, Each Representing a 1/1,000th Interest in a 5.625% Fixed Rate Perpetual Non- Cumulative Preference Share, Series B, par value $1.00 per share

Athersys Inc

ATHENS INTL ARPT S A by ATHENS INTL ARPT SA

ATHENS INTL ARPT SA U/ADR by ATHENS INTL ARPT SA

Athena Technology Acquisition Corp II Warrants (01/01/9999)

Athena Technology Acquisition Corp II

ATHENA TECH ACQ CP II UTS by Athena Technology Acquisition Corp. II

ATHENA TECH ACQ CP II A by Athena Technology Acquisition Corp. II

Athenex Inc

ATHENS WTR&SWGE PUB EYDAP by Athens Water & Sewage Public Co. Eydap

Athens Water Supply & Sewerage Co

News

Press Releases

General

Alterity Therapeutics Prominently Featured at the International MSA Congress

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

Health Care

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Alterity Therapeutics to Present at the Biotech Showcase

Financing

Alterity Therapeutics Raises A$20.0 million in Strategic Placement

Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting

Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson's Disease and Movement Disorders

Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders

ABVC BioPharma

Adicet Bio

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Alterity Therapeutics

BeyondSpring

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

Cibus

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

CervoMed

CEL-SCI

Fortress Biotech

Gain Therapeutics

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

Immix Biopharma

Immunic

Lite Strategy

OKYO Pharma

PMV Pharma

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Plus Therapeutics

Pelthos Therapeutics

Repare Therapeutics

Sutro Biopharma

Unicycive Therapeutics, Inc. - Common Stock

Comments

Alterity Therapeutics

Alterity Therapeutics (ATHE) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL